tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MEDP Stock Latest News

Medpace price target raised to $660 from $655 at Mizuho
The FlyMedpace price target raised to $660 from $655 at Mizuho
5d ago
MEDP
Medpace price target raised to $525 from $485 at Barclays
PremiumThe Fly
Medpace price target raised to $525 from $485 at Barclays
30d ago
MEDP
Jefferies says market thinking ‘backwards’ on FDA one trial proposal
PremiumThe Fly
Jefferies says market thinking ‘backwards’ on FDA one trial proposal
1M ago
IQV
FTRE
FDA shift in drug study requirements sends trial runners lower
PremiumThe Fly
FDA shift in drug study requirements sends trial runners lower
1M ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe Fly
FDA to reduce number of trials required for drug approvals, STAT reports
1M ago
AZN
BMY
Medpace initiated with a Market Perform at BMO Capital
PremiumThe FlyMedpace initiated with a Market Perform at BMO Capital
2M ago
MEDP
Medpace Holdings Inc: Key Update on the OPAL Study for Lymphoid Malignancies
Premium
Company Announcements
Medpace Holdings Inc: Key Update on the OPAL Study for Lymphoid Malignancies
3M ago
MEDP
Medpace and AVM Biotechnology’s Promising ARDS Study: A Potential Game Changer
Premium
Company Announcements
Medpace and AVM Biotechnology’s Promising ARDS Study: A Potential Game Changer
3M ago
MEDP
Medpace and Telix Collaborate on Promising Phase 3 Study for Advanced Kidney Cancer
PremiumCompany Announcements
Medpace and Telix Collaborate on Promising Phase 3 Study for Advanced Kidney Cancer
3M ago
MEDP
Medpace and Radiopharm Launch Promising Cancer Study with 177LuBetaBart
PremiumCompany Announcements
Medpace and Radiopharm Launch Promising Cancer Study with 177LuBetaBart
3M ago
MEDP
Medpace and Radiopharm Theranostics Advance Brain Metastases Imaging Study
PremiumCompany Announcements
Medpace and Radiopharm Theranostics Advance Brain Metastases Imaging Study
3M ago
MEDP
Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study
PremiumCompany Announcements
Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study
3M ago
EWTX
MEDP
Tenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
PremiumCompany AnnouncementsTenax Therapeutics Advances Phase 3 Study on Levosimendan for PH-HFpEF
3M ago
MEDP
TENX
Medpace Holdings Inc: A New Frontier in Carotid Artery Treatment
Premium
Company Announcements
Medpace Holdings Inc: A New Frontier in Carotid Artery Treatment
3M ago
MEDP
Medpace price target raised to $555 from $436 at Truist
Premium
The Fly
Medpace price target raised to $555 from $436 at Truist
3M ago
MEDP
Medpace price target raised to $462 from $356 at TD Cowen
PremiumThe Fly
Medpace price target raised to $462 from $356 at TD Cowen
3M ago
MEDP
Medpace price target raised to $613 from $491 at Baird
PremiumThe Fly
Medpace price target raised to $613 from $491 at Baird
3M ago
MEDP
Medpace price target raised to $655 from $575 at Mizuho
PremiumThe Fly
Medpace price target raised to $655 from $575 at Mizuho
3M ago
MEDP
Medpace price target raised to $485 from $425 at Barclays
PremiumThe Fly
Medpace price target raised to $485 from $425 at Barclays
3M ago
MEDP
Medpace Holdings Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsMedpace Holdings Reports Strong Q3 2025 Results
3M ago
MEDP
Medpace Holdings Inc. Reports Strong Q3 2025 Growth
Premium
Company Announcements
Medpace Holdings Inc. Reports Strong Q3 2025 Growth
3M ago
MEDP
Medpace Holdings: Overvaluation Concerns Amid Growth Projections and Market Positioning
Premium
Ratings
Medpace Holdings: Overvaluation Concerns Amid Growth Projections and Market Positioning
3M ago
MEDP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >